Capricor Therapeutics (STU:4LN2) FFO


STU:4LN2 Capricor Therapeutics Inc STU:4LN2
38 GF Score
Price €20.38
GF Value €4.31
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Capricor Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

STU:4LN2
38GF Score
Capricor Therapeutics Inc STU:4LN2
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Capricor Therapeutics (STU:4LN2) Overvalued in 2026?

Based on GuruFocus' analysis, Capricor Therapeutics stock appears to be overvalued. The current stock price of €20.38 is trading 372.9% above its estimated GF Value™ of €4.31. GuruFocus considers Capricor Therapeutics to be Significantly Overvalued.

Key valuation signals for STU:4LN2:

  • FFO:
  • GF Value™: €4.31 vs. price of €20.38 (372.9% above fair value)
  • GF Score™: 38/100 with 3 warning signs

No single metric tells the full story. See the STU:4LN2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Capricor Therapeutics Business Description

Other Exchanges CAPR:USA
Address 10865 Road to the Cure, Suite 150, San Diego, CA, USA, 92121
Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.
38GF Score

Get the complete analysis for STU:4LN2

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€20.38
Price
€4.31
GF Value